Brisbane Clinical Trials
The Balance Study
The purpose of this study is to investigate a potential new treatment for bacterial, fungal, or mixed vaginitis that has the potential to act more rapidly than other treatments for mixed vaginitis
11 nights
1 phone call + 2 visits
Vaginal infections are common infections of the female reproductive tract and can be classified into more than ten types depending on the cause of the infection. Mixed vaginitis is a vaginal infection caused by two or more pathogenic microorganisms that is difficult to diagnose and treat.
It is hoped that this drug would provide a more effective treatment than the other drugs that are currently available.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Eligibility
Biological Sex Healthy females
Age 18 - 55 years old
BMI 18 - 32kg/m²
Body Weight 50 - 100 kg
Medical History No significant medical history
Medications Not taking any medication
Smoking History Non-smokers and casual smokers only